Beren Therapeutics

FDA Approves First Drug Shown to Help Kids With Infantile-Onset Niemann-Pick Live Longer
The FDA approved Lembaz (adrabetadex) on Nov. 17 for infantile-onset Niemann-Pick disease type C, the first therapy shown to reduce the risk…

The FDA approved Lembaz (adrabetadex) on Nov. 17 for infantile-onset Niemann-Pick disease type C, the first therapy shown to reduce the risk…